EUVIMEDObjevte EUVIMED
Systematische ÜbersichtStudienprotokollOpen access

Targeted Next-Generation Sequencing for Improved Clinical Outcomes in People Living With Rare Diseases in Global South: Protocol for a Systematic Review and Meta-Synthesis

Mapaseka Seheri iD, Dini Mawela iD, Lerato Kgosana iD, Chantelle Baker iD, Wesley Van Hougenhouck-Tulleken iD, Olanrewaju Oladimeji iD

JMIR Research Protocols · 2026-07-03 · 15 · e85150

DOI: 10.2196/85150 ↗

At a glance

Systematische Übersicht in JMIR Research Protocols, published online on 2026-07-03. Written by Mapaseka Seheri and 5 co-authors. Institution: Diarrheal Pathogens Research Unit (DPRU), Department of Medical Virology, School of Medicine, Sefako Makgatho Health Sciences University, Pretoria, G…. Major MEDLINE topics: Rare Diseases, High-Throughput Nucleotide Sequencing. 22 references. The full text is freely available in PubMed Central.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Rare diseases affect many individuals and pose major challenges in diagnosis and treatment, especially in Global South countries where health care resources are limited. Targeted next-generation sequencing (NGS) has significantly advanced diagnostic accuracy and clinical care for rare diseases globally; however, its implementation and impact within the Global South context remain insufficiently studied.

Objective

This study aims to evaluate the use, clinical benefits, challenges, and implementation outcomes of targeted NGS for diagnosing and managing rare diseases in Global South populations. Specifically, it seeks to quantify the diagnostic yield of NGS, examine its influence on subsequent clinical decision-making, and identify principal barriers to, and facilitators of, the implementation of targeted NGS approaches in these contexts.

Methods

This protocol follows the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. We will systematically search PubMed, Scopus, and Web of Science for studies published between 2005 and 2025 that report on the use of targeted NGS in Global South population with rare diseases. Two reviewers will independently perform study selection, data extraction, quality assessment, and evaluation of risk of bias by using QUADAS-2 for diagnostic accuracy studies and the risk of bias assessment tool for nonrandomized studies. Meta-analyses will be conducted to estimate pooled outcomes for diagnostic yield, with heterogeneity assessed using random effects models. Heterogeneity will be further examined through visual inspection of forest plots and by evaluating the chi-square test and I² statistic.

Results

The protocol has been registered with PROSPERO (CRD420251078455). Database search or screening, data extraction, and data synthesis are planned to commence in June 2026 and conclude by September 2026. Study findings will synthesize the diagnostic yield, clinical impact, and contextual determinants influencing the implementation of targeted NGS in Global South health care settings.

Conclusions

This review will provide evidence on the application, advantages, limitations, and clinical outcomes of targeted NGS for individuals affected by rare diseases in countries of the Global South. The finding will identify priorities for capacity strengthening, policy development, and future genomic research. Trial Registration PROSPERO CRD420251078455; https://www.crd.york.ac.uk/PROSPERO/view/CRD420251078455 International Registered Report Identifier (IRRID) PRR1-10.2196/85150

Subjects

MeSH terms (MEDLINE)

Rare DiseasesHigh-Throughput Nucleotide SequencingHumansSystematic Reviews as TopicMeta-Analysis as TopicResearch Design

Author keywords

Global Southdiagnostic yieldgenomic medicinerare diseasestargeted next-generation sequencing

Authors and institutions

  • Diarrheal Pathogens Research Unit (DPRU), Department of Medical Virology, School of Medicine, Sefako Makgatho Health Sciences University, Pretoria, Gauteng, South Africa.
  • Department of Paediatrics and Child Health, School of Medicine, Sefako Makgatho Health Sciences University, Pretoria, Gauteng, South Africa.
  • Electron Microscope Unit, School of Medicine, Sefako Makgatho Health Sciences University, Pretoria, Gauteng, South Africa.
  • Department of Nephrology, School of Medicine, Sefako Makgatho Health Sciences University, Pretoria, Gauteng, South Africa.
  • Department of Public Health, Sefako Makgatho Health Sciences University, Pretoria, Gauteng, South Africa.
  • SAMRC/SMU Public Health Interventions, Innovations and lmplementation Research Unit, Sefako Makgatho Health Sciences University, Pretoria, Gauteng, South Africa.

ORCID profiles: Mapaseka Seheri, Dini Mawela, Lerato Kgosana, Chantelle Baker, Wesley Van Hougenhouck-Tulleken, Olanrewaju Oladimeji

Cite

APA

Seheri, M., Mawela, D., Kgosana, L., Baker, C., Van Hougenhouck-Tulleken, W., & Oladimeji, O. (2026). Targeted Next-Generation Sequencing for Improved Clinical Outcomes in People Living With Rare Diseases in Global South: Protocol for a Systematic Review and Meta-Synthesis. JMIR Research Protocols, 15, e85150. https://doi.org/10.2196/85150

Vancouver

Seheri M, Mawela D, Kgosana L, Baker C, Van Hougenhouck-Tulleken W, Oladimeji O. Targeted Next-Generation Sequencing for Improved Clinical Outcomes in People Living With Rare Diseases in Global South: Protocol for a Systematic Review and Meta-Synthesis. JMIR Research Protocols. 2026;15:e85150. doi:10.2196/85150

BibTeX
@article{Seheri2026,
  author = {Seheri, Mapaseka and Mawela, Dini and Kgosana, Lerato and Baker, Chantelle and Van Hougenhouck-Tulleken, Wesley and Oladimeji, Olanrewaju},
  title = {Targeted Next-Generation Sequencing for Improved Clinical Outcomes in People Living With Rare Diseases in Global South: Protocol for a Systematic Review and Meta-Synthesis},
  journal = {JMIR Research Protocols},
  year = {2026},
  volume = {15},
  pages = {e85150},
  doi = {10.2196/85150}
}
Start for free →